Agilent to close NMR unit with loss of 300 jobs
Agilent Technologies is to exit its Nuclear Magnetic Resonance (NMR) business because it has not met growth and profit targets.
Archives for October 14, 2014
Global regulators demanding needless drug quality levels, says Indian Gov
Overzealous and unnecessary quality demands by some regulatory agencies are driving up the cost of medicines, according to the Indian Government.
Free trade and strong IP held back Ebola vaccine development says NGO
The lack of an Ebola vaccine decades after the virus was discovered is due in part to IP protections in trade deals like TTIP that discourage innovation according to NGO, Health Action International (HAI).
news from the edqm 50th anniversary conference
Food supplements are Europe's real counterfeit drug problem says AIFA expert
Drug active ingredients in food supplements are Europe’s real falsified medicines problem according to the head of AIFA’s counterfeit prevention team.
ISI Group gets behind Quintiles while downgrading Pfizer's strategic partners ICON and Parexel
The investment bank ISI Group has selected Quintiles as its preferred CRO while concurrently downgrading Pfizer’s strategic partners Parexel and ICON.
WHO slams pharma for failing to invest in 'non-profitable' Ebola R&D
The WHO has accused biopharma firms of failing to invest in R&D to tackle Ebola due to the disease’s prevalence in poor African nations, as the death toll surpasses 4,000.